• BioXmark
  • PetXmark
  • Cancer types
  • About
  • News
  • Contact
  • News
  • Events

News

26 November 2020

Capital increase of DKK 36.5 million completed to accelerate growth

Read more

19 November 2020

Nanovi exhibits at the ESTRO 2020 congress

Read more

16 September 2020

Publication of the technology behind Nanovi’s liquid fiducial markers reveals broad application potential in radiation therapy and surgery

Read more

15 September 2020

BioXmark® improves target delineation and is suitable for Small Animal Image-Guided Radiation Therapy (SAIGRT)

Read more

12 August 2020

BioXmark® demonstrates good performance and safety for IGRT in bladder cancer

Read more

8 June 2020

BioXmark® shows good feasibility and clinical performance in esophageal cancer IGRT study

Read more

3 March 2020

Nanovi earns CE mark approval for BioXmark®, its novel liquid fiducial marker

Read more

25 November 2019

Global radiation therapy market specialist joins Nanovi’s board of directors

Read more

27 August 2019

Nanovi raises new capital

Read more

24 January 2019

Nanovi strengthens its Board of Directors and Management

Read more
  • 1
  • 2
  • →

Nanovi A/S

Diplomvej 378

DK-2800 Kgs. Lyngby

info@nanovi.com

+45 3841 4059

CVR: 34 88 90 31

© Nanovi A/S 2021

 

Privacy Notice

 

 

sales@nanovi.com

 

 

 

About    |    News

LinkedIn